TrialCancer immunology, immunotherapy : CII2011

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.

Stéphane Oudard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.